약물 및 비약물 자극에 의한 도파민 유리 영상 = Imaging of Dopamine Release Induced by Pharmacologic and Nonpharmacologic Stimulations

참고문헌 (Reference)

1 Strafella AP, "Therapeutic application of transcranial magnetic stimulation in Parkinson′s disease: the contribution of expectation" 31 : 1666-1672, 2006

2 Karreman M, "The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area" 66 : 589-598, 1996

3 Shetty N, "The placebo response in Parkinson′s disease. Parkinson Study Group" 22 : 207-212, 1999

4 Levine JD, "The mechanism of placebo analgesia" 654-7, lancet1978

5 Barrett SP, "The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride" 54 : 65-71, 2004

6 Rothwell JC, "Techniques and mechanisms of action of transcranial magnetic stimulation of the human motor cortex" 74 : 113-122, 1997

7 Khan A, "Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the FDA database" 57 : 311-317, 2000

8 Strafella AP, "Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex" 126 : 2609-2615, 2003

9 Pogarell O, "Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: Preliminary results of a dynamic [123I] IBZM SPECT study" 40 : 307-314, 2006

10 Brody AL, "Smoking-induced ventral striatum dopamine release" 161 : 1211-1218, 2004

11 Kim YK, "Smoking-Induced dopamine release studied with [11C]raclopride PET" 39 : 421-429, 2005

12 Staley JK, "Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers" 41 : 275-284, 2001

13 Di Chiara G, "Role of dopamine in the behavioral actions of nicotine related to addiction" 393 : 295-314, 2000

14 Ryan M, "Restless legs syndrome" 63 : 1599-1612, 2006

15 Strafella AP, "Repetitive Transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus" 21 : 1-4, 2001

16 Dagher A, "Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers" 42 : 48-53, 2001

17 Chouvet O, "Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo" go (go): 53-6, 1993

18 Padberg F, "Prefrontal cortex modulation of mood and emotionally induced facial expressions:a transcranial magnetic stimulation study" 3 : 206-212, 2001

19 Colloca L, "Placebos and painkillers: is mind as real as matter?" 6 : 545-552, 2005

20 Walsh BT, "Placebo response in studies of major depression: variable, substantial, and growing" 287 : 1840-1847, 2002

21 Schwartz RD, "Nicotinic cholinergic receptor binding sites in the brain regulation in vivo" 214-6, science1983

22 Amanzio M, "Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning- activated specific subsystems" 19 : 484-494, 1999

23 Benedetti F, "Neurobiological mechanisms of the placebo effect" 25 : 10390-10402, 2005

24 Rahman S, "Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study" 129 : 415-424, 2004

25 Kalivas PW, "Neural systems for behavioral activation and reward" 9 : 223-227, 1999

26 Cropley VL, "Molecular imaging of the dopaminergic system and its association with human cognitive function" 59 : 898-907, 2006

27 Kozel FA, "Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression" 8 : 270-275, 2002

28 Bortolomasi M, "Long-lasting effects of high frequency repetitive transcranial magnetic stimulation in major depressed patients" 150 : 181-186, 2007

29 Wassermann EM, "Local and distant changes in cerebral glucose metabolism during repetitive transcranial magnetic stimulation (rTMS)" 48 : 1997

30 Andersson K, "Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smoke" 1 15-2 29, jneuraltransm1986

31 Salokangas RK, "High levels of dopamine activity in the basal ganglia of cigarette smokers" 157 : 632-634, 2000

32 Kaasinen V, "Expectation of caffeine induces dopaminergic responses in humans" 19 : 2352-2356, 2004

33 Volkow ND, "Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers" 23 : 11461-11468, 2003

34 Ohnishi T, "Endogenous dopamine release induced by repetitive transcranial magnetic stimulation over the primary motor cortex: an [11C]raclopride positron emission tomography study in anesthetized macaque monkeys" 55 : 484-489, 2004

35 Taber MT, "Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors" 15 : 3896-3904, 1995

36 Kuroda Y, "Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression" 95 (95): 35-42, 2006

37 Pontieri FE, "Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs" 382 : 206-207, 1996

38 Jung IS, "Effect of acute and chronic nicotine administration on dopamine uptake in tat striatum" in press 2007

39 Koob GF, "Drugs of abuse pharmacology and function of reward pathways" 177-84, trendspharmacolsci1992

40 Rowell PP, "Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors" 68 : 1982-1989, 1997

41 Tan EK, "Dose-dependent protective effect of coffee, tea, and smoking in Parkinson′s disease: a study in ethnic Chinese" 216 : 163-167, 2003

42 Kaasinen V, "Dopaminergic effects of caffeine in the human striatum and thalamus" 15 : 281-285, 2004

43 de la Fuente-Fernandez R, "Dopamine release in human ventral striatum and expectation of reward" 136 : 359-363, 2002

44 Cho SS, "Dopamine release in human striatum induced by repetitive transcranial magnetic stimulation over dorsolateral prefrontal cortex" 2006

45 Coen KM, "Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus" 817-20,

46 Strafella AP, "Corticostriatal functional interactions in Parkinson′s disease: a rTMS/[11C]raclopride PET study" 22 : 2946-2952, 2005

47 Paus T, "Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation" 14 : 1405-1411, 2001

48 Crooks PA, "Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking" 54 : 743-753, 1997

49 Benedetti F, "Conscious expectation and unconscious conditioning in analgesic, motor and hormonal placebo/nocebo responses" 23 : 4315-4323, 2003

50 Daly JW, "Caffeine-an atypical drug of dependence" 51 (51): 199-206, 1998

51 Ferre S, "Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia" 20 : 482-487, 1997

52 Loo CK, "A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression" 37 : 341-349, 2007

53 Walsh V, "A primer of magnetic stimulation as a tool for neuropsychology" 37 : 125-135, 1999

54 Dewey SL, "A pharmacologic strategy for the treatment of nicotine addiction" 31 : 76-86, 1999